Saturday, January 14, 2006


Saliva Hep C Test Developed (Chronic Hepatitis C)


Saliva Hep C Test Developed
Red Herring - Israeli researchers have developed a test for the hepatitis C virus (HCV) based on a sample of saliva, suggesting mass screening for the liver disease may be possible in parts of the developing world where blood testing is less feasible. The aim

Files on infected blood destroyed
BBC UK - The UK Government has admitted that nearly all its files on the infection of patients through NHS blood products have been destroyed. Hundreds of haemophiliacs and other patients were infected with hepatitis C or HIV in the 1980s and early 1990s. The

Updates from JP Morgan's 24th Annual Healthcare Conference
Boston Globe - Anyone who still believes that a halo of glamour surrounds the life of a globetrotting money manager needed to be in the lobby of the St. Francis Hotel in San Francisco this morning, where at 7:45 with picturesque cable cars climbing through a

Can heavy sweating during sleep be related to smoking marijuana or
Better Health Channel - Q27. I have a boyfriend who smokes pot and I hate it. He knows, but when I sleep next to him, he sweats really bad. Is this because of the drugs or is it because of Hep C? l was reading about Hep C which explained that people with this condition

Ask the Doctor: Herbal Remedy for Hepatitis? (Chronic Hepatitis C)


Ask the Doctor: Herbal Remedy for Hepatitis?
RedNova - Dec 19 1:23 PM
Dear Readers: Several months ago, Dr. Alfred McNair, a board-certified gastro-enterologist, wrote a guest column about hepatitis. I've never received as many responses to a column as I received from this column.Save to My Web

U of S scientists develop promising hep C vaccine
CBC Saskatchewan - Jan 11 1:01 PM
There's no cure for hepatitis C, but scientists at the University of Saskatchewan think they've found a pretty good candidate for an effective vaccine.Save to My Web

Health Business
UPI - Jan 09 1:17 PM
CAMBRIDGE, Mass., Jan. 9 (UPI) -- Vertex said Monday its protease inhibitor VX-950 used with standard therapy dramatically cuts hepatitis C (HCV) viral loads.Save to My Web

Valeant Pharmaceuticals Completes Acquisition of Hep-C Drug Infergen(R) From InterMune
[Press Release] Business Wire via Yahoo! Finance - Jan 03 5:30 AM
COSTA MESA, Calif.----Jan. 3, 2006--Valeant Pharmaceuticals International today announced that it has completed its acquisition of the United States and Canadian rights to the hepatitis C drug Infergen from InterMune, Inc. following early termination by the U.S.Save to My Web

Friday, January 13, 2006


Valeant Pharmaceuticals Completes Acquisition of Hep-C Drug ... (Chronic Hepatitis C)


Valeant Pharmaceuticals Completes Acquisition of Hep-C Drug ...
Genetic Engineering News, NY - Jan 3, 2006Valeant Pharmaceuticals International (NYSE:VRX) today announced that it has completed its acquisition of the United States and Canadian rights to the ...

Coastal Monmouth Support Groups
Asbury Park Press, NJ - Dec 24, 2005... HEP-C SUPPORT: Hepatitis C Challenge meets 7-9 pm the third Thursday of the month, Jersey Shore Wellness Center, 2020 Route 33, second floor conference room ...

Northern Ocean Support Groups
Asbury Park Press, NJ - Dec 24, 2005... HEP-C SUPPORT: MOCHCCI-Hepatitis C support group meets 7-9 pm the first Tuesday of the month in the lower-level conference room at Ocean Medical Center, 425 ...

Thursday, January 12, 2006


Chronic Hepatitis C Treatment, Peg-Intron(R) And Rebetol(R ... (Chronic Hepatitis C)


Chronic Hepatitis C Treatment, Peg-Intron(R) And Rebetol(R ...
Schering-Plough Corporation (NYSE: SGP) announced that Schering-Plough K.

Management of Chronic Hepatitis C: Clinical Focus
How well do the results of initial liver biopsy predict measures of disease progression and outcomes of treatment in patients with chronic hepatitis C, ...

Hepatitis C (infectious liver inflammation type C)
Hepatitis is the Latin word for liver inflammation. Type C hepatitis is caused by a virus called hepatitis C virus. It was previously referred to as ...

Hepatitis C Top Articles
Chronic hepatitis C virus (HCV) infection affects approximately 3 million people in ... Is HCV Viral Load a Predictor of Progression of Chronic Hepatitis C? ...

Hepatitis C: FAQ | CDC Viral Hepatitis (Chronic Hepatitis C)


Hepatitis C: FAQ | CDC Viral Hepatitis
Can children receive interferon therapy for chronic hepatitis C? ... It is common for persons with chronic hepatitis C to have a liver enzyme level that ...

Children with chronic Hepatitis C benefit from interferon with ...
Nearly half of 118 children with chronic Hepatitis C virus (HCV) treated with a combination of interferon-alpha-2b and an optimized dose of ribavirin ...

HIV and Hepatitis.com Coverage of the 45th Interscience Conference ...
56th AASLD HIV-HCV Coinfected Patients Receive Treatment for Chronic Hepatitis C Less Frequently Than HCV Monoinfected - 12/05/05 ...

Hepatitis B and C -- familydoctor.org
What are chronic hepatitis B and chronic hepatitis C? *, How does a person get hepatitis B or C? *, What are the symptoms of acute hepatitis B or C? ...

Tuesday, January 10, 2006


Hepatitis Prevention Programs (Chronic Hepatitis C)


Hepatitis Prevention Programs
Organizations with national and local hepatitis C support group information Local support groups listed by state/area Hepatitis B information Frequently asked questions about hepatitis B virus

Hepatitis C - Alternative Treatment for Hepatitis Alchemist Lab
We provide education and treatment for Hepatitis C. To understand our approach to HepC go to Treatment Principles. In Blood Tests and Signs/Symptoms we

index.html
of the patients with chronic hepatitis C, including some with advanced cirrhosis and liver failure. If you are cured, your viral level falls to undetectable during

Hepatitis C health and medical information produced by doctors
Medical information about Hepatitis C and related Liver disorders About Us | Privacy Policy MedicineNet Home > Hepatitis C Home Page search help Hepatitis C Overview Digestion Newsletter Hepatitis C Drug

Monday, January 09, 2006


Hepatitis C (Chronic Hepatitis C)


Hepatitis C
Hepatitis C. By Howard J. Worman, MD. NEW: The Hepatitis C Sourcebook. By Howard J. Worman, MD. The Hepatitis C Virus (HCV) ...

NIDA - NIDA Community Drug Alert Bulletin - Hepatitis
Hepatitis C infection is caused by the hepatitis C virus, also known as HCV, ... Acquisition of hepatitis C infection is very rapid among new injectors ...

Hepatitis C Virus Infection in Cocaine Users: A Silent Epidemic
The presence of Hepatitis C infection in cocaine users who thought they were healthy suggests a silent epidemic in an unsuspecting population.

OIVD: Home-Use Tests - Hepatitis C
Hepatitis C infection is caused by the hepatitis C virus (HCV). ... Hepatitis C infection is the number 1 cause for liver transplantation in the US. ...

Sunday, January 08, 2006


Anadys Pharmaceuticals Selects a Novel Oral Toll-Like Receptor Ligand as Drug Development Candidate for Cancer (Chronic Hepatitis C)


Anadys Pharmaceuticals Selects a Novel Oral Toll-Like Receptor Ligand as Drug Development Candidate for Cancer
FinanzNachrichten - Dec 13 1:17 PM
SAN DIEGO, Dec. 13 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals ( Nachrichten ), Inc. announced today that it has selected ANA773, a novel Toll-Like Receptor-7 (TLR-7) oral prodrug, for its next clinical development program.Save to My Web

Medivir: Candidate Drug Designated within the Tibotec Collaboration
[Press Release] Business Wire via Yahoo! Finance - Dec 28 11:59 PM
STOCKHOLM, Sweden----Dec. 29, 2005--The Hepatitis C Virus collaboration with Tibotec Pharmaceuticals Ltd has recently designated a Candidate Drug . The aim of the research collaboration is to identify and develop orally active inhibitors of the HCV protease NS3/4A.Save to My Web

Cyclosporine Shows Advantage Over Tacrolimus
RedNova - Jan 06 7:50 PM
The immunosuppressive agent cyclosporine has shown better efficacy than the leading anti-rejection drug tacrolimus when taken as an adjunctive therapy by liver transplant patients with hepatitis C.Save to My Web

A Summary of Chronic Hepatitis C InfectionHepatitis C (Chronic Hepatitis C)

A Summary of Chronic Hepatitis C Infection

Hepatitis C is a stealthy virus that mutates while hiding in liver cells and other organ cells like the spleen and gall bladder. The fact that the viral cells "hide" makes it very difficult for the body's immune system to eradicate it. Hepatitis C is a slowly progressing disease sometimes taking many years until symptoms are noticeable. It is at this point that the virus has reached advanced chronic stage and becomes difficult to eradicate. Hepatitis C results in 8,000 to 10,000 deaths annually. Hepatitis C is also the leading cause of liver transplants in the U.S.

Hepatitis C infection is caused by blood contact with someone who has the virus infection himself. The transmission of the virus can occur by illicit drug use with needles, sharing toothbrushes or razors with an infected person, by sexual means, by unsanitary tattooing or by exposure to blood at your workplace (like a hospital or blood bank). Some HCV infection may have been caused by receiving blood from a transfusion prior to 1992.

Hepatitis C is diagnosed via a blood test. Usually, the first thing that is noticed is that the liver enzyme levels for ALT and AST are elevated well above normal levels. Further investigation via HCV-RNA testing identifies whether the Hepatitis C virus is in your blood or not. Other tests for HCV include qualitative viral load tests, which measure the RNA particles in your blood. If you are being treated for HCV, your doctor is probably using either a HCV-RNA or viral load test to determine the effectiveness of the treatment.

The symptoms of Hepatitis C infection often do not occur in a person until 20 years after he/she had been infected. Since the HCV infects the liver and the liver is the organ in the body that makes all the energy for our daily activities possible, liver function deterioration often results in fatigue. Fatigue is the primary complaint or symptom of HCV infection. Other more severe symptoms are jaundice (yellowing of the skin/eyes), bile retention (which can cause jaundice), portal vein hypertension, skin rashes and itching, and autoimmune problems resulting from your body's immune system attacking normal cells.

Long term HCV infection may result in fibrosis or even cirrhosis of the liver. Fibrosis results from unchecked liver inflammation. As the HCV infection progresses, the damage to the liver results in scarring or hardening of the liver cells (fibrosis). Long term fibrosis may lead to cirrhosis which is when the scarring from fibrosis overtakes the normal liver cell structure causing deformity and loss of function in the liver. About 15%-20% of HCV patients end up with cirrhosis. A liver biopsy is currently the most accurate means of determining the amount of inflammation and fibrosis the liver has sustained.

Hepatitis C progression in the body can take several years or even decades to come to chronic stage or to a stage where severe liver damage is evident. This period of time allows a person to determine how to properly treat the disease and to decide on a course of disease management. Currently, the main treatment for HCV infection to eradicate the virus is combo alpha-interferon and Ribavirin. Sometimes a doctor may prescribe interferon alone. Interferon comes in standard form or in pegylated form. Standard form interferon is administered 3 times per week, while the pegylated form is administered only once per week. Your body makes its own interferon, which is a protein that fights viral infection and viral replication.

Hepatitis C may often be managed by taking herbal and vitamin supplements that help your body fight infection and limit inflammation. These supplements help your liver with the inflammation and give it the nutrients it needs to regenerate healthy new cells. Your doctor can recommend alternative or adjunct solutions you may want to try.

Proper treatment of the disease, a healthy and active lifestyle, a good diet, abstinence from alcohol and stress management are important factors in controlling Hepatitis C progression.

About the Author

Greg Lietz is a freelance writer and internet businessman. His main website is http://www.theonlinebizplace.com where he provides content about internet based business opportunities and different niche interests. This article may be freely printed when the bio information is included.